Faster access than browser!Similarities between Pancreatic cancer and Pancreatic neuroendocrine tumor
Pancreatic cancer and Pancreatic neuroendocrine tumor have 46 things in common (in Unionpedia): Adenocarcinoma, American Joint Committee on Cancer, ATRX, Cell (biology), Chemotherapy, Clinical trial, Death-associated protein 6, Endocrine system, Everolimus, Fluorouracil, Food and Drug Administration, Gallstone, Gastrin, Gastrinoma, Gene, Glucagon, Glucagonoma, Grading (tumors), Hormone, Hypoglycemia, Insulin, Insulinoma, Malignancy, MEN1, Metastasis, MTOR, Multiple endocrine neoplasia type 1, Neoplasm, Nervous system, Neuroendocrine cell, ..., Neuroendocrine tumor, Octreotide, Oncology, Pancreas, Pancreatic cancer, Pancreatic islets, Peptic ulcer disease, Peptide, Prognosis, Somatostatinoma, Sunitinib, Targeted therapy, VIPoma, Von Hippel–Lindau disease, World Health Organization, Zollinger–Ellison syndrome. Expand index (16 more) »
Adenocarcinoma
Adenocarcinoma (plural adenocarcinomas or adenocarcinomata) is a type of cancerous tumor that can occur in several parts of the body.
Adenocarcinoma and Pancreatic cancer · Adenocarcinoma and Pancreatic neuroendocrine tumor ·
American Joint Committee on Cancer
The American Joint Committee on Cancer (AJCC) is an organization best known for defining and popularizing cancer staging standards, officially the AJCC staging system.
American Joint Committee on Cancer and Pancreatic cancer · American Joint Committee on Cancer and Pancreatic neuroendocrine tumor ·
ATRX
Transcriptional regulator ATRX also known as ATP-dependent helicase ATRX, X-linked helicase II, or X-linked nuclear protein (XNP) is a protein that in humans is encoded by the ATRX gene.
ATRX and Pancreatic cancer · ATRX and Pancreatic neuroendocrine tumor ·
Cell (biology)
The cell (from Latin cella, meaning "small room") is the basic structural, functional, and biological unit of all known living organisms.
Cell (biology) and Pancreatic cancer · Cell (biology) and Pancreatic neuroendocrine tumor ·
Chemotherapy
Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen.
Chemotherapy and Pancreatic cancer · Chemotherapy and Pancreatic neuroendocrine tumor ·
Clinical trial
Clinical trials are experiments or observations done in clinical research.
Clinical trial and Pancreatic cancer · Clinical trial and Pancreatic neuroendocrine tumor ·
Death-associated protein 6
Death-associated protein 6 also known as Daxx is a protein that in humans is encoded by the DAXX gene.
Death-associated protein 6 and Pancreatic cancer · Death-associated protein 6 and Pancreatic neuroendocrine tumor ·
Endocrine system
The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs, and the feedback loops of homeostasis that the hormones drive.
Endocrine system and Pancreatic cancer · Endocrine system and Pancreatic neuroendocrine tumor ·
Everolimus
No description.
Everolimus and Pancreatic cancer · Everolimus and Pancreatic neuroendocrine tumor ·
Fluorouracil
Fluorouracil (5-FU), sold under the brand name Adrucil among others, is a medication used to treat cancer.
Fluorouracil and Pancreatic cancer · Fluorouracil and Pancreatic neuroendocrine tumor ·
Food and Drug Administration
The Food and Drug Administration (FDA or USFDA) is a federal agency of the United States Department of Health and Human Services, one of the United States federal executive departments.
Food and Drug Administration and Pancreatic cancer · Food and Drug Administration and Pancreatic neuroendocrine tumor ·
Gallstone
A gallstone is a stone formed within the gallbladder out of bile components. The term cholelithiasis may refer to the presence of gallstones or to the diseases caused by gallstones. Most people with gallstones (about 80%) never have symptoms. When a gallstone blocks the bile duct, a crampy pain in the right upper part of the abdomen, known as biliary colic (gallbladder attack) can result. This happens in 1–4% of those with gallstones each year. Complications of gallstones may include inflammation of the gallbladder (cholecystitis), inflammation of the pancreas (pancreatitis), jaundice, and infection of a bile duct (cholangitis). Symptoms of these complications may include pain of more than five hours duration, fever, yellowish skin, vomiting, dark urine, and pale stools. Risk factors for gallstones include birth control pills, pregnancy, a family history of gallstones, obesity, diabetes, liver disease, or rapid weight loss. The bile components that form gallstones include cholesterol, bile salts, and bilirubin. Gallstones formed mainly from cholesterol are termed cholesterol stones, and those mainly from bilirubin are termed pigment stones. Gallstones may be suspected based on symptoms. Diagnosis is then typically confirmed by ultrasound. Complications may be detected on blood tests. The risk of gallstones may be decreased by maintaining a healthy weight through sufficient exercise and eating a healthy diet. If there are no symptoms, treatment is usually not needed. In those who are having gallbladder attacks, surgery to remove the gallbladder is typically recommended. This can be carried out either through several small incisions or through a single larger incision, usually under general anesthesia. In rare cases when surgery is not possible medication may be used to try to dissolve the stones or lithotripsy to break down the stones. In developed countries, 10–15% of adults have gallstones. Rates in many parts of Africa, however, are as low as 3%. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013 and they resulted in 106,000 deaths. Women more commonly have stones than men and they occur more commonly after the age of 40. Certain ethnic groups have gallstones more often than others. For example, 48% of Native Americans have gallstones. Once the gallbladder is removed, outcomes are generally good.
Gallstone and Pancreatic cancer · Gallstone and Pancreatic neuroendocrine tumor ·
Gastrin
Gastrin is a peptide hormone that stimulates secretion of gastric acid (HCl) by the parietal cells of the stomach and aids in gastric motility.
Gastrin and Pancreatic cancer · Gastrin and Pancreatic neuroendocrine tumor ·
Gastrinoma
A gastrinoma is a tumor in the pancreas or duodenum that secretes excess of gastrin leading to ulceration in the duodenum, stomach and the small intestine.
Gastrinoma and Pancreatic cancer · Gastrinoma and Pancreatic neuroendocrine tumor ·
Gene
In biology, a gene is a sequence of DNA or RNA that codes for a molecule that has a function.
Gene and Pancreatic cancer · Gene and Pancreatic neuroendocrine tumor ·
Glucagon
Glucagon is a peptide hormone, produced by alpha cells of the pancreas.
Glucagon and Pancreatic cancer · Glucagon and Pancreatic neuroendocrine tumor ·
Glucagonoma
A glucagonoma is a rare tumor of the alpha cells of the pancreas that results in the overproduction of the hormone glucagon.
Glucagonoma and Pancreatic cancer · Glucagonoma and Pancreatic neuroendocrine tumor ·
Grading (tumors)
In pathology, grading is a measure of the cell appearance in tumors and other neoplasms.
Grading (tumors) and Pancreatic cancer · Grading (tumors) and Pancreatic neuroendocrine tumor ·
Hormone
A hormone (from the Greek participle “ὁρμῶ”, "to set in motion, urge on") is any member of a class of signaling molecules produced by glands in multicellular organisms that are transported by the circulatory system to target distant organs to regulate physiology and behaviour.
Hormone and Pancreatic cancer · Hormone and Pancreatic neuroendocrine tumor ·
Hypoglycemia
Hypoglycemia, also known as low blood sugar, is when blood sugar decreases to below normal levels.
Hypoglycemia and Pancreatic cancer · Hypoglycemia and Pancreatic neuroendocrine tumor ·
Insulin
Insulin (from Latin insula, island) is a peptide hormone produced by beta cells of the pancreatic islets; it is considered to be the main anabolic hormone of the body.
Insulin and Pancreatic cancer · Insulin and Pancreatic neuroendocrine tumor ·
Insulinoma
An insulinoma is a tumor of the pancreas that is derived from beta cells and secretes insulin.
Insulinoma and Pancreatic cancer · Insulinoma and Pancreatic neuroendocrine tumor ·
Malignancy
Malignancy is the tendency of a medical condition to become progressively worse.
Malignancy and Pancreatic cancer · Malignancy and Pancreatic neuroendocrine tumor ·
MEN1
Menin is a protein that in humans is encoded by the MEN1 gene.
MEN1 and Pancreatic cancer · MEN1 and Pancreatic neuroendocrine tumor ·
Metastasis
Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; it is typically spoken of as such spread by a cancerous tumor.
Metastasis and Pancreatic cancer · Metastasis and Pancreatic neuroendocrine tumor ·
MTOR
The mammalian target of rapamycin (mTOR), also known as the mechanistic target of rapamycin and FK506-binding protein 12-rapamycin-associated protein 1 (FRAP1), is a kinase that in humans is encoded by the MTOR gene.
MTOR and Pancreatic cancer · MTOR and Pancreatic neuroendocrine tumor ·
Multiple endocrine neoplasia type 1
Multiple endocrine neoplasia type 1 (MEN-1 syndrome) or Wermer's syndrome is part of a group of disorders, the multiple endocrine neoplasias, that affect the endocrine system through development of neoplastic lesions in pituitary, parathyroid gland and pancreas.
Multiple endocrine neoplasia type 1 and Pancreatic cancer · Multiple endocrine neoplasia type 1 and Pancreatic neuroendocrine tumor ·
Neoplasm
Neoplasia is a type of abnormal and excessive growth of tissue.
Neoplasm and Pancreatic cancer · Neoplasm and Pancreatic neuroendocrine tumor ·
Nervous system
The nervous system is the part of an animal that coordinates its actions by transmitting signals to and from different parts of its body.
Nervous system and Pancreatic cancer · Nervous system and Pancreatic neuroendocrine tumor ·
Neuroendocrine cell
Neuroendocrine cells are cells that receive neuronal input (neurotransmitters released by nerve cells or neurosecretory cells) and, as a consequence of this input, release message molecules (hormones) to the blood.
Neuroendocrine cell and Pancreatic cancer · Neuroendocrine cell and Pancreatic neuroendocrine tumor ·
Neuroendocrine tumor
Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems.
Neuroendocrine tumor and Pancreatic cancer · Neuroendocrine tumor and Pancreatic neuroendocrine tumor ·
Octreotide
Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone.
Octreotide and Pancreatic cancer · Octreotide and Pancreatic neuroendocrine tumor ·
Oncology
Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
Oncology and Pancreatic cancer · Oncology and Pancreatic neuroendocrine tumor ·
Pancreas
The pancreas is a glandular organ in the digestive system and endocrine system of vertebrates.
Pancreas and Pancreatic cancer · Pancreas and Pancreatic neuroendocrine tumor ·
Pancreatic cancer
Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to multiply out of control and form a mass.
Pancreatic cancer and Pancreatic cancer · Pancreatic cancer and Pancreatic neuroendocrine tumor ·
Pancreatic islets
The pancreatic islets or islets of Langerhans are the regions of the pancreas that contain its endocrine (hormone-producing) cells, discovered in 1869 by German pathological anatomist Paul Langerhans.
Pancreatic cancer and Pancreatic islets · Pancreatic islets and Pancreatic neuroendocrine tumor ·
Peptic ulcer disease
Peptic ulcer disease (PUD) is a break in the lining of the stomach, first part of the small intestine or occasionally the lower esophagus.
Pancreatic cancer and Peptic ulcer disease · Pancreatic neuroendocrine tumor and Peptic ulcer disease ·
Peptide
Peptides (from Gr.: πεπτός, peptós "digested"; derived from πέσσειν, péssein "to digest") are short chains of amino acid monomers linked by peptide (amide) bonds.
Pancreatic cancer and Peptide · Pancreatic neuroendocrine tumor and Peptide ·
Prognosis
Prognosis (Greek: πρόγνωσις "fore-knowing, foreseeing") is a medical term for predicting the likely or expected development of a disease, including whether the signs and symptoms will improve or worsen (and how quickly) or remain stable over time; expectations of quality of life, such as the ability to carry out daily activities; the potential for complications and associated health issues; and the likelihood of survival (including life expectancy).
Pancreatic cancer and Prognosis · Pancreatic neuroendocrine tumor and Prognosis ·
Somatostatinoma
Somatostatinoma is a malignant tumor of the delta cells of the endocrine pancreas that produces somatostatin.
Pancreatic cancer and Somatostatinoma · Pancreatic neuroendocrine tumor and Somatostatinoma ·
Sunitinib
Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006.
Pancreatic cancer and Sunitinib · Pancreatic neuroendocrine tumor and Sunitinib ·
Targeted therapy
Targeted therapy or molecularly targeted therapy is one of the major modalities of medical treatment (pharmacotherapy) for cancer, others being hormonal therapy and cytotoxic chemotherapy.
Pancreatic cancer and Targeted therapy · Pancreatic neuroendocrine tumor and Targeted therapy ·
VIPoma
A VIPoma (also known as Verner–Morrison syndrome, after the physicians who first described it) is a rare (1 per 10,000,000 per year) endocrine tumor, usually (about 90%) originating from non-β islet cell of the pancreas, that produce vasoactive intestinal peptide (VIP).
Pancreatic cancer and VIPoma · Pancreatic neuroendocrine tumor and VIPoma ·
Von Hippel–Lindau disease
von Hippel–Lindau disease (VHL), also known as Familial cerebello retinal angiomatosis, is a rare genetic disorder with multisystem involvement.
Pancreatic cancer and Von Hippel–Lindau disease · Pancreatic neuroendocrine tumor and Von Hippel–Lindau disease ·
World Health Organization
The World Health Organization (WHO; French: Organisation mondiale de la santé) is a specialized agency of the United Nations that is concerned with international public health.
Pancreatic cancer and World Health Organization · Pancreatic neuroendocrine tumor and World Health Organization ·
Zollinger–Ellison syndrome
Zollinger–Ellison syndrome (ZES) is a disease in which tumors cause the stomach to produce too much acid, resulting in peptic ulcers.
Pancreatic cancer and Zollinger–Ellison syndrome · Pancreatic neuroendocrine tumor and Zollinger–Ellison syndrome ·
The list above answers the following questions
- What Pancreatic cancer and Pancreatic neuroendocrine tumor have in common
- What are the similarities between Pancreatic cancer and Pancreatic neuroendocrine tumor
Pancreatic cancer and Pancreatic neuroendocrine tumor Comparison
Pancreatic cancer has 295 relations, while Pancreatic neuroendocrine tumor has 85. As they have in common 46, the Jaccard index is 12.11% = 46 / (295 + 85).
References
This article shows the relationship between Pancreatic cancer and Pancreatic neuroendocrine tumor. To access each article from which the information was extracted, please visit:
